
 
 
 
 
 
 
 
 
   
 1. A method of inhibiting the growth of a glioma cell, the method comprising contacting said glioma cell with a therapeutically effective amount of compound of formula II: 
 
 
 
 
   
   
 
 
 such that growth of said glioma cell is inhibited. 
 
 
     
 2. A method of inhibiting the growth of a glioma cell, the method comprising contacting said glioma cell with a therapeutically effective amount of a compound of formula I: 
 
 
 
 
   
   
 
 
 such that growth of said glioma cell is inhibited, wherein; 
 W 1 , W 2  and W 3  is each independently selected from —CH═CH—; 
 
 
 
 
 
   
   
 
 
 A is selected from —NH—, —NCH 2 R 1 , —NC(O)R 1 ; 
 R 1  is selected from C 1-6  alkyl, C 2-6  alkene, aryl or heteroaryl; 
 R 2 , R 3 , and R 4  is each independently selected from H, R 5 , —C(O)R 6    
 R 5  is each independently selected from C 1-6  alkyl, C 2-7  alkalene, aryl or heteroaryl; and 
 R 6  is each independently selected from H, C 1-6  alkyl, C 2-7  alkalene, aryl or heteroaryl. 
 
 
     
 3. The method of  claim 2 , wherein A of said compound is NH. 
 
     
 4. The method of  claim 2 , wherein A of said compound is —NCH 2 R 1 . 
 
     
 5. The method of  claim 2 , wherein A of said compound is —NC(O)R 1 . 
 
     
 6. The method of  claim 2 , wherein R 2  of said compound is H. 
 
     
 7. The method of  claim 2 , wherein R 3  of said compound is H. 
 
     
 8. The method of  claim 2 , wherein R 4  of said compound is H. 
 
     
 9. The method of  claim 2 , wherein R 2 , R 3  and R 4  of said compound are each H. 
 
     
 10. The method of  claim 2 , wherein R 2 , R 3  and R 4  of said compound are each H, and W 1  is —CH═CH—. 
 
     
 11. The method of  claim 2 , wherein R 2 , R 3  and R 4  of said compound are each H, and W 2  is —CH═CH—. 
 
     
 12. The method of  claim 2 , wherein R 2 , R 3  and R 4  of said compound are each H, and W 3  is —CH═CH—. 
 
     
 13. The method of  claim 2 , wherein A of said compound is NH and R 2 , R 3  and R 4  are each H. 
 
     
 14. The method of  claim 2 , wherein A of said compound is NH, and each of W 1 , W 2 , and W 3  is —CH═CH—. 
 
     
 15. A method of treating a glioma in a mammal, comprising the step of administering to said mammal a therapeutically effective amount of the compound of formula II: 
 
 
 
 
   
   
 
 
 such that said glioma is treated. 
 
 
     
 16. A method of treating a glioma in a mammal, comprising the step of administering a therapeutically effective amount of the compound of formula I to a mammal having a glioma: 
 
 
 
 
   
   
 
 
 
 such that said glioma is treated, wherein:
 W 1 , W 2  and W 3  is each independently selected from —CH═CH— 
 
 
 
 
 
   
   
 
 
 A is selected from —NH—, —NCH 2 R 1 , —NC(O)R 1 ; 
 R 1  is selected from C 1-6  alkyl, C 2-6  alkene, aryl or heteroaryl; 
 R 2 , R 3 , and R 4  is each independently selected from H, R 5 , —C(O)R 6    
 R 5  is each independently selected from C 1-6  alkyl, C 2-7  alkalene, aryl or heteroaryl; and 
 R 6  is each independently selected from H, C 1-6  alkyl, C 2-7  alkalene, aryl or heteroaryl. 
 
 
     
 17. The method of  claim 16 , wherein A of said compound is NH. 
 
     
 18. The method of  claim 16 , wherein A of said compound is —NCH 2 R 1 . 
 
     
 19. The method of  claim 16 , wherein A of said compound is —NC(O)R 1 . 
 
     
 20. The method of  claim 16 , wherein R 2  of said compound is H. 
 
     
 21. The method of  claim 16 , wherein R 3  of said compound is H. 
 
     
 22. The method of  claim 16 , wherein R 4  of said compound is H. 
 
     
 23. The method of  claim 16 , wherein R 2 , R 3  and R 4  of said compound are each H. 
 
     
 24. The method of  claim 16 , wherein R 2 , R 3  and R 4  of said compound are each H, and W 1  is —CH═CH—. 
 
     
 25. The method of  claim 16 , wherein R 2 , R 3  and R 4  of said compound are each H, and W 2  is —CH═CH—. 
 
     
 26. The method of  claim 16 , wherein R 2 , R 3  and R 4  of said compound are each H, and W 3  is —CH═CH—. 
 
     
 27. The method of  claim 16 , wherein A of said compound is NH and R 2 , R 3  and R 4  are each H. 
 
     
 28. The method of  claim 16 , wherein A of said compound is NH, and each of W 1 , W 2 , and W 3  is —CH═CH—. 
 
     
 29. The method of  claim 2 , wherein said administering is oral. 
 
     
 30. The method of  claim 2 , wherein said administering is intravenous. 
 
     
 31. The method of  claim 2 , wherein said administering is intraperitoneal. 
 
     
 32. The method of  claim 16 , wherein said administering is oral. 
 
     
 33. The method of  claim 16 , wherein said administering is intravenous. 
 
     
 34. The method of  claim 16 , wherein said administering is intraperitoneal. 
 
   
 
 
 
 
 
 
 
 
